Literature DB >> 18560362

HOming in on arteriovenous fistula survival.

W Durante1, C-C Lin.   

Abstract

Vascular access failure is a major clinical problem for patients on hemodialysis, but therapeutic approaches aimed at improving arteriovenous fistula (AVF) dysfunction remain elusive. Using a murine AVF model, Juncos et al. demonstrate for the first time that the stress protein heme oxygenase-1 (HO-1) is induced in AVFs and that HO-1 is a critical determinant of AVF survival.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18560362      PMCID： PMC2645071          DOI： 10.1038/ki.2008.127

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  10 in total

1.  Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.

Authors:  C-C Lin; W-C Yang; S-J Lin; T-W Chen; W-S Lee; C-F Chang; P-C Lee; S-D Lee; T-S Su; C S-J Fann; M-Y Chung
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 2.  Hemodialysis vascular access morbidity.

Authors:  H I Feldman; S Kobrin; A Wasserstein
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

3.  Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation.

Authors:  Robert Ollinger; Martin Bilban; Anna Erat; Alberto Froio; James McDaid; Shivraj Tyagi; Eva Csizmadia; Aurelio V Graça-Souza; Angela Liloia; Miguel P Soares; Leo E Otterbein; Anny Usheva; Kenichiro Yamashita; Fritz H Bach
Journal:  Circulation       Date:  2005-08-08       Impact factor: 29.690

4.  Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells.

Authors:  C T Wagner; W Durante; N Christodoulides; J D Hellums; A I Schafer
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

5.  Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model.

Authors:  Y Castier; S Lehoux; Y Hu; G Foteinos; G Fonteinos; A Tedgui; Q Xu
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

6.  Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients.

Authors:  Chih-Ching Lin; Chao-Fu Chang; Ming-Yu Lai; Tzen-Wen Chen; Pui-Ching Lee; Wu-Chang Yang
Journal:  J Am Soc Nephrol       Date:  2007-01-31       Impact factor: 10.121

7.  Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1.

Authors:  Chih-Ching Lin; Xiao-Ming Liu; Kelly Peyton; Hong Wang; Wu-Chang Yang; Shing-Jong Lin; William Durante
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-17       Impact factor: 8.311

8.  Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse.

Authors:  J P Juncos; M J Tracz; A J Croatt; J P Grande; A W Ackerman; Z S Katusic; K A Nath
Journal:  Kidney Int       Date:  2008-03-26       Impact factor: 10.612

Review 9.  Vascular stenosis: biology and interventions.

Authors:  Prabir Roy-Chaudhury; Timmy C Lee
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-11       Impact factor: 2.894

Review 10.  Role of carbon monoxide in cardiovascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310
  10 in total
  7 in total

1.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 2.  The Biology of Hemodialysis Vascular Access Failure.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  MCP-1 contributes to arteriovenous fistula failure.

Authors:  Julio P Juncos; Joseph P Grande; Lu Kang; Allan W Ackerman; Anthony J Croatt; Zvonimir S Katusic; Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2010-11-29       Impact factor: 10.121

Review 4.  Therapeutic strategies to combat neointimal hyperplasia in vascular grafts.

Authors:  Michael J Collins; Xin Li; Wei Lv; Chenzi Yang; Clinton D Protack; Akihito Muto; Caroline C Jadlowiec; Chang Shu; Alan Dardik
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-05

5.  Heme Oxygenase 1/Peroxisome Proliferator-Activated Receptor Gamma Pathway Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula Dysfunction by Regulating Oxidative Stress and Inflammatory Response.

Authors:  Tingfei Xie; Yunpeng Xu; Lecai Ji; Xiaolu Sui; Aisha Zhang; Yanzi Zhang; Jihong Chen
Journal:  Cardiovasc Ther       Date:  2022-06-12       Impact factor: 3.368

6.  A high red blood cell distribution width predicts failure of arteriovenous fistula.

Authors:  Krzysztof Bojakowski; Mensur Dzabic; Ewa Kurzejamska; Grzegorz Styczynski; Piotr Andziak; Zbigniew Gaciong; Cecilia Söderberg-Nauclér; Piotr Religa
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

Review 7.  Sex Differences in Inflammation During Venous Remodeling of Arteriovenous Fistulae.

Authors:  Shin Mei Chan; Gabe Weininger; John Langford; Daniel Jane-Wit; Alan Dardik
Journal:  Front Cardiovasc Med       Date:  2021-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.